BCR and Burkitt lymphoma: To test the importance of these adaptors, we used pull‐down assays to analyze interactions of endophilin A2‐GFP with the BCR in DG75 Burkitt lymphoma cells in the context of GRB2 or BLNK deletion (Vanshylla et al,2018).